Sterling Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Sterling Capital Management's RMD Position: Q2 2026 in Review
Sterling Capital Management increased its ResMed (RMD) stake by 9.2% in Q2 2026, buying an estimated $76.9K and bringing the position to 4,387 shares worth $855K. The position accounts for 0.01% of the portfolio, ranked #608.
Sterling Capital Management first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.97M in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Sterling Capital Management held 4,387 shares of ResMed worth $855K as of Q2 2026.
- Sterling Capital Management bought 371 ResMed shares in Q2 2026, an estimated $76.9K.
- ResMed made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #608 holding.
- Sterling Capital Management first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
- Sterling Capital Management's ResMed position peaked at $1.97M in Q2 2025.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.